Tenon Medical is trading at $4.59, up 13.59%, with no clear October 2 catalyst identified for the live-session rise.
- The company announced the full commercial launch of its SImmetry+ system on September 30. Its alpha launch generated approximately $1.2 million in incremental revenue, but this earlier news does not establish the reason for the current move.
- Broader indexes are higher, but available evidence does not show that this explains Tenon Medical’s gain.